Searched over 200M research papers
10 papers analyzed
These studies suggest that pancreatic, liver, lung, esophageal, and brain cancers have the lowest survival rates.
20 papers analyzed
Pancreatic ductal adenocarcinoma (PDAC) is widely recognized as the cancer with the lowest survival rate among major cancers. The 5-year survival rate for pancreatic cancer is alarmingly low, standing at approximately 8.2% . This dismal prognosis is attributed to several factors, including late diagnosis, aggressive disease progression, and high rates of chemoresistance.
Despite advancements in cancer treatment, the survival rates for pancreatic cancer have shown minimal improvement over the years. Studies indicate that the 5-year survival rate for pancreatic cancer remains below 20% globally, with some regions reporting even lower rates. For instance, in the United States, the 5-year survival rate for pancreatic cancer is one of the lowest among all cancer types .
Liver cancer also ranks among the cancers with the lowest survival rates. The 5-year survival rate for liver cancer is generally below 20% worldwide, with some countries reporting rates as low as 7-9%. This low survival rate is consistent across various regions, including Europe, North America, and Asia .
Lung cancer is another major cancer with a low survival rate. The 5-year survival rate for lung cancer typically ranges between 10% and 20% in most regions. The highest reported survival rate is in Japan at 32.9%, while the lowest is in India at 3.7%. Despite some improvements over the past decades, lung cancer remains one of the most lethal cancers globally .
Esophageal cancer also has a notably low survival rate. The 5-year survival rate for esophageal cancer varies significantly by region but generally remains low. For example, in Japan, the 5-year survival rate for esophageal cancer is 36.0%, which is relatively higher compared to other regions.
Pancreatic cancer stands out as the cancer with the lowest survival rate, with a 5-year survival rate of approximately 8.2%. Liver, lung, and esophageal cancers also have low survival rates, often below 20%. These statistics highlight the urgent need for improved early detection methods, more effective treatments, and comprehensive cancer care strategies to enhance survival outcomes for these particularly lethal cancers.
Most relevant research papers on this topic